NEW
YORK, Dec. 6, 2022 /PRNewswire/ -- IFF
(NYSE: IFF) has unveiled research in partnership with the
Universidad Católica San Antonio
de Murcia (UCAM), demonstrating that the AB-Fortis® iron
ingredient is significantly better tolerated than a common iron
salt. AB-Fortis® is an iron salt encapsulated in
alginate—a natural seaweed-derived polysaccharide—making the
ingredient appropriate for vegetarians and vegans. This unique
encapsulation technology is particularly robust under high pressure
and temperature during processing. AB-Fortis® maintains
its encapsulation in the stomach to avoid triggering
gastrointestinal (GI) discomfort, and then releases iron in the
intestine for optimal absorption.
![](https://mma.prnewswire.com/media/1962314/AB_Fortis_image_credit.jpg)
Globally, iron deficiency is a pervasive health
concern[1]. The
need for iron supplementation has increased due to the prevalence
of conditions such as celiac disease, irritable bowel syndrome
(IBS), chronic kidney and heart diseases, and the growing adoption
of vegetarian and vegan lifestyles. Iron supplementation compliance
can be a challenge due to low bioavailability and its potential
side effects, which may include metallic taste and gastrointestinal
discomfort.
In a study published in the International Journal of
Molecular Sciences and funded by IFF, results suggest that the
consumption of an iron supplement in the formulation of a
microencapsulated ferric preparation (MFS) is associated with a
better tolerability profile when compared to ferrous sulphate (FS),
a commonly used iron supplement. The single-center, crossover,
randomized, double-blind, and controlled clinical study
investigating the effect of MFS on healthy pre-menopausal women
demonstrates that AB-Fortis® is very well tolerated,
even at a relatively high dose of 60 milligrams of elemental iron.
It has significantly fewer GI side effects such as constipation,
diarrhea, nausea and epigastric distress than FS[2].
"We're pleased to partner with UCAM in this research to
demonstrate that our premium iron ingredient, AB-Fortis®
has excellent oral tolerability," said Ryan
Lauchli, global health category manager, IFF Health. "Iron
can be hard to tolerate for many who take supplements, but our
natural encapsulation is a great solution for our customers to
incorporate into many different dietary supplements and food
formats. We are proud to be able to deliver an efficacious
ingredient to the industry so consumers can benefit."
This microencapsulated iron is produced using a unique patented
technology. It is protected by an organic layer that minimizes the
release of free iron into the food and does not produce a metallic
taste. The 40 percent high iron content in the microcapsule allows
it to be used in small dosages, and does not change the appearance,
palatability or taste of fortified foods.
To learn more about IFF Health and AB-Fortis® visit
www.iff-health.com.
[1] World Health
Organization. Anaemia.
|
[2] Friling, M. et
al. Tolerability of Oral Supplementation with Microencapsulated
Ferric Saccharate Compared to Ferrous Sulphate in Healthy
Premenopausal Woman: A Crossover, Randomized, Double-Blind Clinical
Trial. Int. J. Mol. Sci. 2022, 23(20),
12282
|
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage,
health, biosciences and scent, science and creativity meet to
create essential solutions for a better world – from global icons
to unexpected innovations and experiences. With the beauty of art
and the precision of science, we are an international collective of
thinkers who partners with customers to bring scents, tastes,
experiences, ingredients and solutions for products the world
craves. Together, we will do more good for people and planet. Learn
more at iff.com, Twitter , Facebook, Instagram,
and LinkedIn.
©2022 International Flavors & Fragrances Inc. (IFF). IFF,
the IFF Logo, and all trademarks and service marks denoted with ™,
SM or ® are owned by IFF or affiliates of IFF unless
otherwise noted. All Rights Reserved.
Contact:
Victoria Oldridge
Global Communications Specialist
+1 415-307-2164
Victoria.Oldridge@iff.com
SOURCE IFF